CN Patent

CN118086311B — 抑制PCSK9基因表达的siRNA、其缀合物和药物组合物及用途

Assigned to Suzhou Shian Biotechnology Co ltd · Expires 2024-08-09 · 2y expired

What this patent protects

本发明涉及一种抑制PCSK9基因表达的siRNA、其缀合物和药物组合物及用途，所述siRNA包括正义链和反义链，所述siRNA中的每个核苷酸各自独立地为修饰或未修饰的核苷酸，所述正义链包括如SEQ ID NO:1至22中任一项所示序列，所述反义链包括如SEQ ID NO:23至44中任一项所示序列。

USPTO Abstract

本发明涉及一种抑制PCSK9基因表达的siRNA、其缀合物和药物组合物及用途，所述siRNA包括正义链和反义链，所述siRNA中的每个核苷酸各自独立地为修饰或未修饰的核苷酸，所述正义链包括如SEQ ID NO:1至22中任一项所示序列，所述反义链包括如SEQ ID NO:23至44中任一项所示序列。

Drugs covered by this patent

Patent Metadata

Patent number
CN118086311B
Jurisdiction
CN
Classification
—
Expires
2024-08-09
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Shian Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.